SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Leticia de Paula Scalioni, Helena Medina Cruz, Vanessa Salete de Paula, Juliana Custódio Miguel, Vanessa Alves Marques, Cristiane Alves Villela-Nogueira, Flavio Augusto Pádua Milagres, Marcelo Santos Cruz, Francisco Inácio Bastos, Tarcisio Matos Andrade, Ana Rita Coimbra Motta-Castro, Lia Laura Lewis-Ximenez, Elisabeth Lampe, Livia Melo Villar, Performance of rapid hepatitis C virus antibody assays among high- and low-risk populations, Journal of Clinical Virology, 2014, 60, 3, 200

    CrossRef

  2. 2
    J. Chen, T. C. Cesario, P. M. Rentzepis, Rationale and mechanism for the low photoinactivation rate of bacteria in plasma, Proceedings of the National Academy of Sciences, 2014, 111, 1, 33

    CrossRef

  3. 3
    Mark Thursz, Arnaud Fontanet, HCV transmission in industrialized countries and resource-constrained areas, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 1, 28

    CrossRef

  4. 4
    Juliane Kant, Bernd Möller, Renate Heyne, Adam Herber, Stephan Böhm, Melanie Maier, Uwe G. Liebert, Joachim Mössner, Thomas Berg, Johannes Wiegand, Evaluation of a rapid on-site anti-HCV test as a screening tool for hepatitis C virus infection, European Journal of Gastroenterology & Hepatology, 2012, 1

    CrossRef

  5. 5
    Ali Oguz Er, Jie Chen, Thomas C. Cesario, P. M. Rentzepis, Inactivation of bacteria in plasma, Photochemical & Photobiological Sciences, 2012, 11, 11, 1700

    CrossRef

  6. 6
    D N Assis, J K Lim, New Pharmacotherapy for Hepatitis C, Clinical Pharmacology & Therapeutics, 2012, 92, 3
  7. 7
    Stephen R. Lee, Keith W. Kardos, Eugene Schiff, Cheryl A. Berne, Karam Mounzer, Alpha T. Banks, Harvey A. Tatum, Timothy J. Friel, Michael P. DeMicco, William M. Lee, Scott E. Eder, Alexander Monto, Graham D. Yearwood, Geraldine B. Guillon, Lisa A. Kurtz, Mark Fischl, Jay Lynn Unangst, Laura Kriebel, Gary Feiss, Michele Roehler, Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid, Journal of Virological Methods, 2011, 172, 1-2, 27

    CrossRef

  8. 8
    S.R. Lee, G.D. Yearwood, G.B. Guillon, L.A. Kurtz, M. Fischl, T. Friel, C.A. Berne, K.W. Kardos, Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection, Journal of Clinical Virology, 2010, 48, 1, 15

    CrossRef

  9. You have free access to this content9
    Marc G. Ghany, Doris B. Strader, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009, 49, 4
  10. 10
    Régis Peffault de Latour, Patricia Ribaud, Marie Robin, Dominique Valla, Patrick Marcellin, Gérard Socié, Tarik Asselah, Allogeneic hematopoietic cell transplant in HCV-infected patients, Journal of Hepatology, 2008, 48, 6, 1008

    CrossRef

  11. 11
    Janaína L. Narciso-Schiavon, Leonardo L. Schiavon, Roberto J. Carvalho-Filho, Jaqueline R. Cardoso, Fernanda C.F. Freire, Juliana P. Sampaio, José O. Bordin, Maria Angélica Soares, Antonio Eduardo B. Silva, Maria Lucia G. Ferraz, Anti-HCV reactive blood donors: clinical and epidemiological factors associated with false-reactive results, European Journal of Gastroenterology & Hepatology, 2008, 20, 11, 1071

    CrossRef

  12. 12
    A. Scott Muerhoff, Robin Gutierrez, Charles Kyrk, Thomas Leary, George Schlauder, George Dawson, Suresh M. Desai, Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies, Journal of Medical Virology, 2008, 80, 3
  13. 13
    Mandy Whitlock, Sandra Lord, Jane A. Buxton, Patrick Doyle, Mark Bigham, Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005, Transfusion, 2007, 47, 8
  14. 14
    Michael P. Busch, Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis, Transfusion, 2006, 46, 9
  15. 15
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  16. 16
    F. Fabrizi, A. F. De Vecchi, G. Como, G. Lunghi, P. Martin, De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay, Alimentary Pharmacology & Therapeutics, 2005, 21, 7
  17. 17
    N Pentón, A Musacchio, J.M Rivera, J Roca, M Ponce, D Rodríguez, A Caballero, Y.I Tallo, R.E Narciandi, Antigenicity of a recombinant NS3 protein representative of ATPase/helicase domain from hepatitis C virus, Clinical Biochemistry, 2003, 36, 1, 41

    CrossRef

  18. 18
    Usha K. Sharma, Susan L. Stramer, David J. Wright, Simone A. Glynn, Sigurd Hermansen, George B. Schreiber, Steven H. Kleinman, Michael P. Busch, Impact of changes in viral marker screening assays, Transfusion, 2003, 43, 2
  19. 19
    A Scott Muerhoff, George J. Dawson, Viral Hepatitis: Molecular Biology, Diagnosis, Epidemiology and Control, 2003,

    CrossRef

  20. 20
    Susanna Swilley, Donald K. Strickland, Rene Davila, Mark Levstik, Raul Ribeiro, Melissa M. Hudson, Hepatitis C infection during treatment for childhood cancer: Pitfalls in diagnosis and management, Medical and Pediatric Oncology, 2002, 39, 1
  21. 21
    Judith C. Brillman, Cameron S. Crandall, Christopher S. Florence, Joshua L. Jacobs, Prevalence and risk factors associated with hepatitis C in ED patients, The American Journal of Emergency Medicine, 2002, 20, 5, 476

    CrossRef

  22. 22
    Mostafa K El Awady, Maha A El-Demellawy, Samy B Khalil, Dalia Galal, Said A Goueli, Synthetic peptide-based immunoassay as a supplemental test for HCV infection, Clinica Chimica Acta, 2002, 325, 1-2, 39

    CrossRef

  23. 23
    C. Colin, D. Lanoir, S. Touzet, L. Meyaud-Kraemer, F. Bailly, C. Trepo, Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature, Journal of Viral Hepatitis, 2001, 8, 2
  24. 24
    Roger Dodd, Blood Safety and Surveillance, 2001,

    CrossRef

  25. 25
    Jay Epstein, Mary Gustafson, Blood Safety and Surveillance, 2001,

    CrossRef

  26. 26
    Yizhak Kupfer, Mitchell S. Cappell, Sidney Tessler, ACUTE GASTROINTESTINAL BLEEDING IN THE INTENSIVE CARE UNIT, Gastroenterology Clinics of North America, 2000, 29, 2, 275

    CrossRef

  27. 27
    J. Peterson, G. Green, K. Iida, B. Caldwell, P. Kerrison, S. Bernich, K. Aoyagi, S.R. Lee, Detection of Hepatitis C Core Antigen in the Antibody Negative ‘Window’ Phase of Hepatitis C Infection, Vox Sanguinis, 2000, 78, 2
  28. 28
    David H. Culver, Miriam J. Alter, Robert J. Mullan, Harold S. Margolis, Evaluation of the effectiveness of targeted lookback for HCV infection in the United States—interim results, Transfusion, 2000, 40, 10
  29. 29
    M.P. Busch, K.K. Watanabe, J.W. Smith, S.W. Hermansen, R.A. Thomson, False-negative testing errors in routine viral marker screening of blood donors, Transfusion, 2000, 40, 5
  30. 30
    L.H. Tobler, G. Tegtmeier, S.L. Stramer, S. Quan, J. Dockter, C. Giachetti, M.P. Busch, Lookback on donors who are repeatedly reactiveon first-generation hepatitis C virus assays:justification and rational implementation, Transfusion, 2000, 40, 1
  31. 31
    M.P. Busch, L.H. Tobler, G. Tegtmeier, A. Polito, S. Quan, N.V. Hirschler, J. Dockter, C. Giachetti, L. Mimms, Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback, Transfusion, 2000, 40, 1
  32. 32
    Alejandro Palacios, Lizeth Taylor, Lizbeth Haue, Ronald B. Luftig, Kirsten A. Visoná, Development of low cost peptide-based anti-hepatitis C virus screening and confirmatory assays: Comparison with commercially available tests, Journal of Medical Virology, 1999, 58, 3
  33. 33
    Heinz-Hubert Feucht, Bernhard Zöllner, Matthias Schröter, Susanne Polywka, Peter Buggisch, Hartmut Nolte, Rainer Laufs, High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up, Journal of Clinical Virology, 1999, 13, 1-2, 43

    CrossRef

  34. 34
    JENNIFER L. CLEVELAND, BARBARA F. GOOCH, BRIAN G. SHEARER, ROB L. LYERLA, Risk and Prevention of Hepatitis C Virus Infection, The Journal of the American Dental Association, 1999, 130, 5, 641

    CrossRef

  35. 35
    R. Saxena, V. Thakur, B. Sood, R.C. Guptan, S. Gururaja, S.K. Sarin, Transfusion-Associated Hepatitis in a Tertiary Referral Hospital in India, Vox Sanguinis, 1999, 77, 1
  36. 36
    JJ Lefrère, Biologie moléculaire et sécurité virale transfusionnelle, Transfusion Clinique et Biologique, 1998, 5, 1, 22

    CrossRef

  37. 37
    Miriam J. Alter, Eric E. Mast, Linda A. Moyer, Harold S. Margolis, HEPATITIS C, Infectious Disease Clinics of North America, 1998, 12, 1, 13

    CrossRef

  38. 38
    Ronald L. Paquette, Ken Kuramoto, Lawrence Tran, Ghislaine Sopher, Stephen D. Nimer, Jerome B. Zeldis, Hepatitis C virus infection in acquired aplastic anemia, American Journal of Hematology, 1998, 58, 2
  39. 39
    L. A. Pereboeva, A. V. Pereboev, G. E. Morris, Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries, Journal of Medical Virology, 1998, 56, 2
  40. 40
    Peter M. Engel, Reinhard H. Dennin, Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection, Zentralblatt für Bakteriologie, 1998, 288, 2, 267

    CrossRef

  41. 41
    Peter Hüssy, Heinrich Faust, Jean-Claude Wagner, Georg Schmid, Jan Mous, Helmut Jacobsen, Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening, Journal of Hepatology, 1997, 26, 6, 1179

    CrossRef

  42. 42
    Eric E. Mast, Miriam J. Alter, Hepatitis C, Seminars in Pediatric Infectious Diseases, 1997, 8, 1, 17

    CrossRef

  43. 43
    Regino P. González-Peralta, HEPATITIS C VIRUS INFECTION IN PEDIATRIC PATIENTS, Clinics in Liver Disease, 1997, 1, 3, 691

    CrossRef

  44. 44
    Hans Vrielink, Henk W. Reesink, Peter J.M. Burg, Hans L. Zaaijer, H. Theo M. Cuypers, P. Nico Lelie, Cees L. Poel, Performance of three generations of anti-hepatitis C virus enzyme- linked immunosorbent assays in donors and patients, Transfusion, 1997, 37, 8
  45. 45
    Robin A. Gutierrez, George J. Dawson, Mark F. Knigge, Susan L. Melvin, Cynthia A. Heynen, Charles R. Kyrk, Charles E. Young, Robert J. Carrick, George G. Schlauder, Teresa K. Surowy, Bruce J. Dille, Paul F. Coleman, Dwain L. Thiele, Joseph R. Lentino, Constance Pachucki, Isa K. Mushahwar, Seroprevalence of GB virus C and persistence of RNA and antibody, Journal of Medical Virology, 1997, 53, 2
  46. 46
    David R. Gretch, USE AND INTERPRETATION OF HCV DIAGNOSTIC TESTS IN THE CLINICAL SETTING, Clinics in Liver Disease, 1997, 1, 3, 543

    CrossRef

  47. 47
    M.N. Mayer, M. Montalembert, F. Audat, M.C. Brusset, B. Houfani, J. Merckx, G. Barrier, C. Gazengel, Autologous Blood Donation for Elective Surgery in Children Weighing 8–25 kg, Vox Sanguinis, 1996, 70, 4
  48. 48
    S. J. Wagner, D. Robinette, Evaluation of swirling, pH, and glucose tests for the detection of bacterial contamination in platelet concentrates, Transfusion, 1996, 36, 11-12
  49. 49
    D.D. Eckels, P. Flomenberg, J.C. Gill, Hepatitis C virus: models of immunopathogenesis and prophylaxis, Transfusion, 1996, 36, 9
  50. 50
    Donald B. Smith, Patrizia Pontisso, Heterogeneity of hepatitis C virus, Baillière's Clinical Gastroenterology, 1996, 10, 2, 243

    CrossRef

  51. 51
    PAUL V. HOLLAND, NOTIFICATION AND COUNSELING OF BLOOD DONORS, Vox Sanguinis, 1996, 70, S3
  52. 52
    Y. Nakatsuji, J. Wai-Kuo Shih, E. Tanaka, K. Kiyosawa, J. Wages Jr., J. P. Kim, H. J. Alter, Prevalence and disease association of hepatitis G virus infection in Japan, Journal of Viral Hepatitis, 1996, 3, 6
  53. 53
    George B. Schreiber, Michael P. Busch, Steven H. Kleinman, James J. Korelitz, The Risk of Transfusion-Transmitted Viral Infections, New England Journal of Medicine, 1996, 334, 26, 1685

    CrossRef

  54. 54
    R. Lesniewski, R. Johnson, J. Scheffel, B. Moore, G. Okasinski, R. Carrick, C. Van Sant, S. Desai, I. Mushahwar, Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia, Journal of Medical Virology, 1995, 45, 4
  55. 55
    S. C. Anderson, T. Hathaway, I. K. Kuramoto, P. V. Holland, R. Gilchec, T. Koch, S. Hojvat, Comparison of two second-generation anti-hepatitis C virus ELISA on 21431 US blood donor samples, Journal of Viral Hepatitis, 1995, 2, 1
  56. 56
    G. L. Ornopia, K. Kliramoto, Detection of anti-hepatitis C virus using chemiluminescence, Journal of Viral Hepatitis, 1995, 2, 4
  57. 57
    Antonio González, Juan I. Esteban, Pedro Madoz, Luis Viladomiu, Juan Genesca, Eduardo Muñiz, Jaime Enríquez, Xavier Torras, José M. Hernández, Josep Quer, Xavier Vidal, Harvey J. Alter, James W. Shih, Rafael Esteban, Jaime Guardia, Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: Final report of a prospective trial, Hepatology, 1995, 22, 2
  58. 58
    Kathleen Sazama, Existing Problems in the Testing for Infectious Diseases, Immunological Investigations, 1995, 24, 1-2, 131

    CrossRef

  59. 59
    A.M. Jullien, Hépatite C en pratique transfusionnelle, Médecine et Maladies Infectieuses, 1995, 25, 1074

    CrossRef

  60. 60
    Alberto Zanella, Dario Conte, Daniele Prati, Fulvio Mozzi, Carmen Capelli, Francesco Zanuso, Mirella Fraquelli, Patrizia Bosoni, Luciana Vianello, Marco Pappalettera, Pietro Velio, Glanguido Montagnolo, Paolo A. Bianchi, Girolamo Sirchia, Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay, Hepatology, 1995, 21, 4
  61. 61
    J. M. Barrera, B. Francis, G. Ercilla, M. Nelles, D. Achord, J. Darner, S. R. Lee, Improved Detection of Anti-HCV in Post-Transfusion Hepatitis by a Third-Generation ELISA, Vox Sanguinis, 1995, 68, 1
  62. 62
    S.R. Lee, C.L. Wood, M.J. Lane, B. Francis, C. Gust, C.M. Higgs, M.J. Nelles, A. Polito, R. DiNello, D. Achord, Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay, Transfusion, 1995, 35, 10
  63. 63
    Louis Vaickus, James B. Breitmeyer, Robert L. Schlossmann, Kenneth C. Anderson, Platelet transfusion and alternatives to transfusion in patients with malignancy, STEM CELLS, 1995, 13, 6
  64. 64
    Roger Y. Dodd, Viral Contamination of Blood Components and Approaches for Reduction of Infectivity, Immunological Investigations, 1995, 24, 1-2, 25

    CrossRef

  65. 65
    Nicole Simon, Anne-Marie Couroucé, Nadine Lemarrec, Christian Trépo, Stéphane Ducamp, A twelve year natural history of hepatitis C virus infection in hemodialyzed patients, Kidney International, 1994, 46, 2, 504

    CrossRef

  66. 66
    S. Uyttendaele, H. Claeys, W. Mertens, H. Verhaert, C. Vermylen, Evaluation of Third-Generation Screening and Confirmatory Assays for HCV Antibodies, Vox Sanguinis, 1994, 66, 2
  67. 67
    S. K. Aoki, I. K. Kuramoto, S. Anderson, V. Schoening, R. Rodriguez, L. Fernando, K. Sazama, P. V. Holland, Evidence that use of a second-generation hepatitis C antibody assay prevents additional cases of transfusion-transmitted hepatitis, Journal of Viral Hepatitis, 1994, 1, 1
  68. 68
    Linda A. Moyer, Miriam J. Alter, Hepatitis C Virus in the Hemodialysis Setting: A Review with Recommendations for Control, Seminars in Dialysis, 1994, 7, 2
  69. 69
    Susan P. Buchbinder, Mitchell H. Katz, Nancy A. Hessol, Jennifer Liu, Paul M. O'Malley, Miriam J. Alter, Hepatitis C virus infection in sexually active homosexual men, Journal of Infection, 1994, 29, 3, 263

    CrossRef

  70. 70
    Renate Seelig, M. Renz, Claudia Bottner, H. P. Seelig, Hepatitis C Virus Infections in Dialysis Units: Prevalence of HCV-RNA and Antibodies to HCV, Annals of Medicine, 1994, 26, 1, 45

    CrossRef

  71. 71
    Yu Wang, Qi-Min Tao, Hai-Yan Zhao, Fumio Tsuda, Ryozo Nagayama, Kayoko Yamamoto, Takeshi Tanaka, Hajime Tokita, Hiroaki Okamoto, Yuzo Miyakawa, Makoto Mayumi, Hepatitis C virus RNA and antibodies among blood donors in Beijing, Journal of Hepatology, 1994, 21, 4, 634

    CrossRef

  72. 72
    Satoko Fukuda, Takashi Suzuki, Ryozo Nagayama, Fumio Tsuda, Maki Kojima, Hiroaki Okamoto, Takeshi Tanaka, Yuzo Miyakawa, Makoto Mayumi, Hepatitis C virus RNA in blood units with antibodies detectable by a second-generation passive hemagglutination assay, antibodies to synthetic core peptides or elevated transaminase levels, Transfusion Science, 1994, 15, 1, 83

    CrossRef

  73. 73
    Ryozo Nagayama, Kazuhiko Miyake, Fumio Tsuda, Hiroaki Okamoto, IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C, Journal of Medical Virology, 1994, 42, 3
  74. 74
    Paul V. Holland, Overview: Diagnostic tests for viral infections transmitted by blood, Nuclear Medicine and Biology, 1994, 21, 3, 407

    CrossRef

  75. 75
    H. L. Zaaijer, H. T. M. Cuypers, H. W. Reesink, P. N. Lelie, Should the c100 Antigen Be Removed from HCV Antibody Assays?, Vox Sanguinis, 1994, 66, 2
  76. 76
    P. C. Das, A. Heethuis, R. L. McShine, C. Th. Smtt Sibinga, Supplemental HCV antibody assay in blood donors by RIBA and line immunoassay, Transfusion Medicine, 1994, 4, 2
  77. 77
    R.Y. Dodd, Viral inactivation in platelet concentrates, Transfusion Clinique et Biologique, 1994, 1, 3, 181

    CrossRef

  78. 78
    Louise J. Short, David M. Bell, Risk of occupational infection with blood-borne pathogens in operating and delivery room settings, American Journal of Infection Control, 1993, 21, 6, 343

    CrossRef

  79. 79
    Laboratory Testing of Donated Blood,